Intranasal AD4-H5-VTN as an Adenovirus Vaccine

NCT01806909 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
51
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)